Engineers Gate Manager’s Coherus Oncology CHRS Stock Holding History

Engineers Gate Manager’s Portfolio CHRS Stock Details CHRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-22,658	Closed	-$38.3K	–	2286
2026 Q1	$38.3K	Buy	+22,658	New	+$40.2K	﹤0.01%	2101
2025 Q2	–	Sell	-13,212	Closed	-$10.7K	–	2200
2025 Q1	$10.7K	Buy	+13,212	New	+$15.2K	﹤0.01%	2099
2024 Q4	–	Sell	-11,978	Closed	-$12.5K	–	2264
2024 Q3	$12.5K	Buy	+11,978	New	+$16.4K	﹤0.01%	2050
2022 Q4	–	Sell	-11,915	Closed	-$115K	–	1711
2022 Q3	$115K	Sell	11,915 -22,685	-66%	-$230K	0.01%	1429
2022 Q2	$251K	Sell	34,600 -640	-2%	-$5.57K	0.01%	1522
2022 Q1	$455K	Buy	+35,240	New	+$448K	0.02%	1113
2020 Q2	–	Sell	-42,357	Closed	-$687K	–	1720
2020 Q1	$687K	Sell	42,357 -19,372	-31%	-$358K	0.05%	605
2019 Q4	$1.11M	Buy	+61,729	New	+$1.14M	0.05%	583

Other funds holding CHRS

TGY2IT

Timothy G. Youngquist 2020 Irrevocable Trust Fort Myers, Florida $510M AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return

CWG

C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return

Engineers Gate Manager's CHRS Position: Q2 2026 in Review

Engineers Gate Manager sold out of Coherus Oncology (CHRS) in Q2 2026, closing a stake of 22,658 shares — an estimated $38.3K sold.

Engineers Gate Manager first reported a position in CHRS in Q4 2019 and held it in 8 quarters. The position peaked at $1.11M in Q4 2019. 147 funds tracked by Wall St. Rank hold CHRS as of Q2 2026.

Engineers Gate Manager reported no remaining Coherus Oncology position as of Q2 2026 after selling out during the quarter.
Engineers Gate Manager sold 22,658 Coherus Oncology shares in Q2 2026, an estimated $38.3K.
Engineers Gate Manager first reported a position in Coherus Oncology in Q4 2019 and held it in 8 quarters.
Engineers Gate Manager's Coherus Oncology position peaked at $1.11M in Q4 2019.
147 funds tracked by Wall St. Rank held Coherus Oncology as of Q2 2026.

Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.